Articoli marcati con tag 'bethesda IV'

Today it is possible to specifically evaluate the risk of malignancy of indeterminate thyroid nodules (Thy3 or Bethesda III or Bethesda IV) thanks to molecular genetics. There are several methods: some already validated, internationally recognized, patented and marketed and others experimental, under study and not yet validated. This article will discuss the latest version of the commercial Thyroseq method (Thyroseq V3), the most advanced molecular genetics method in the world.
EndocrinologiaOggi Center, in Rome (Italy), with consolidated experience ...